P589: IMPLICATIONS OF REGISTRY DATA FOR ACUTE MYELOID LEUKEMIA (AML) TREATMENT AND CARE DURING THE COVID-19 PANDEMIC

Bart Scott; Mikkael Sekeres; Guillermo Garcia-Manero; David Grinblatt; Irene Degutis; Pavel Kiselev; Ali Mcbride; Willem Heydendael; Edward Yu; Gail Roboz

doi:10.1097/01.HS9.0000969260.59505.36

Back

P589: IMPLICATIONS OF REGISTRY DATA FOR ACUTE MYELOID LEUKEMIA (AML) TREATMENT AND CARE DURING THE COVID-19 PANDEMIC

Journal article

Peer reviewed

P589: IMPLICATIONS OF REGISTRY DATA FOR ACUTE MYELOID LEUKEMIA (AML) TREATMENT AND CARE DURING THE COVID-19 PANDEMIC

Bart Scott, Mikkael Sekeres, Guillermo Garcia-Manero, David Grinblatt, Irene Degutis, Pavel Kiselev, Ali Mcbride, Willem Heydendael, Edward Yu and Gail Roboz

HemaSphere, Vol.7, p.e5950536

2023-08-08

DOI: https://doi.org/10.1097/01.HS9.0000969260.59505.36

Appears in Miller School of Medicine - Latest Publications

Metrics

1 Record Views

Details

Title: P589: IMPLICATIONS OF REGISTRY DATA FOR ACUTE MYELOID LEUKEMIA (AML) TREATMENT AND CARE DURING THE COVID-19 PANDEMIC
Creators: Bart Scott - Hutchinson
Mikkael Sekeres - Sylvester Comprehensive Cancer Center
Guillermo Garcia-Manero - The University of Texas MD Anderson Cancer Center
David Grinblatt - NorthShore University HealthSystem
Irene Degutis - Bristol-Myers Squibb
Pavel Kiselev - Bristol-Myers Squibb
Ali Mcbride - Bristol-Myers Squibb
Willem Heydendael - Bristol-Myers Squibb
Edward Yu - Bristol-Myers Squibb
Gail Roboz - Cornell College
Publication Details: HemaSphere, Vol.7, p.e5950536
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031921573102976